Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

Higher persistent PSA levels post-surgery were linked to increased mortality risk, with 8-year prostate cancer–specific mortality reaching 13.86% for a prostate-specific antigen (PSA) ≥ 1 ng/mL. The ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...

A large study highlights the importance of earlier and more frequent prostate cancer screening for Black men. While it’s well established that Black men in the United States are more likely to develop ...

Prostate cancer screening for most at risk men has been rejected in Britain and one of the country's top surgeons has explains how one wrong test result can "snowball" Oxford University professor ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...

So, what is the prostate and why does it cause so many problems for men? It's a topic most people don't want to discuss. But it can have a big impact on your life. The prostate is a small organ that ...

Effective cancer screening protocols can dramatically alter outcomes for patients. Prostate cancer, for example, has been one of the most common cancers among men in the United States for decades. In ...

Have you ever wondered what causes poor prostate health in men? Most people with prostate problems think they got the short end of the stick in the draw of life. But it’s not bad luck that you end up ...

Because AGA typically presents decades before the first symptoms of BPH, Arias-Santiago and colleagues suggest that early-onset AGA may be a useful marker for BPH risk later in life. To test this ...